Ice-free sample temperature control
CoolBox eliminates contamination risk and temperature variability of ice
The Mill Valley, California, US-based developer of portable tools for temperature-sensitive biomedical sample handling says the portable and reusable cartridge technology eliminates the risk of contamination and temperature variability associated with the use of ice.
Unlike sealed plastic coolers, which require refreezing overnight, CoolBox gives unlimited cooling by simply switching cartridges, the company says. The cartridges consist of a gel pack with a thermo-conductive alloy shell, which enables fast recharge in a standard –20ºC lab freezer. A single cartridge provides 4–10 hours of ice-free cooling at 0.5ºC to 4ºC depending on whether the CoolBox lid is off or on.
BioCision’s CoolBox PCR96 and CoolBox PCR384 system kits each include one CoolBox Microplate with lid, one CoolRack PCR (either 384- or 96-well) and one +2ºC cooling cartridge. Additional +2ºC cartridges are available separately.
The kit offers iso-temperature control during the entire cooling period and the thermo-conductivity of CoolRack PCR ensures the system will quickly equilibrate to +2ºC, with less than 0.1ºC variation between wells, eliminating temperature inconsistencies between centre and outer rows.
Brian Schryver, BioCision’s vice president of research and product development, says the compact design and ice-free technology make CoolBox an ideal choice for use in tissue culture hoods, biosafety cabinets, GMP suites and other situations where space is restricted or where ice could be a source of contamination.
‘The versatility of the system is unrivalled, with the option of using dry ice rather than a cartridge cooling source, when CoolBox becomes a personal benchtop cryo-station. Samples can be safely snap-frozen, without the use of alcohol, in less than 30 seconds,’ he added.
The CoolBox is lightweight and fracture-proof enabling it to be used for patient or biomedical sample collection.
The CoolBox Microplate is also compatible with CoolSink SBS format thermoconductive multiwell plate holders and CoolRack for 96 x 1ml storage tubes such as those from Matrix or Micronics, among others.
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
Read moreAt Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model
Manufacturing
BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany
The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in the process as it pivots from COVID-19 vaccines to oncology